Related Experiment Video
Updated: Jan 25, 2026

08:51
A New Murine Model of Endovascular Aortic Aneurysm Repair
Published on: July 7, 2013
14.8K
[Tocilizumab for refractory Takayasu arteritis with aortic aneurysm]
F Frikha1, S Garbaa1, Y Bouattour1
1Service de médecine interne, CHU Hédi Chaker, 3029 Sfax, Tunisie.
Journal De Medecine Vasculaire
|April 29, 2019
Summary
Tocilizumab effectively treated a refractory case of Takayasu arteritis (TA) complicated by a giant aortic aneurysm and severe hypertension. This interleukin-6 inhibitor offers a promising option for complex large vessel vasculitis cases.
Area of Science:
- Immunology
- Cardiovascular Medicine
- Rheumatology
Background:
- Takayasu arteritis (TA) is a rare large vessel vasculitis (LVV) affecting the aorta and its branches.
- Refractory cases often require advanced therapeutic strategies.
- Biologic agents, including TNF α and IL-6 inhibitors, have shown promise in managing refractory TA.
Observation:
- A 46-year-old woman presented with refractory TA.
- The patient had complications of a giant aortic aneurysm (AA) and severe hypertension.
- Previous treatments had proven insufficient.
Findings:
- Tocilizumab, an anti-interleukin-6 receptor monoclonal antibody, was administered.
- The treatment demonstrated significant efficacy in managing the refractory TA and its associated complications.
- The patient's condition, including severe hypertension and the aortic aneurysm, showed positive response.
Implications:
- Tocilizumab represents a viable therapeutic option for complex Takayasu arteritis cases.
- This case highlights the potential of IL-6 inhibition in managing refractory LVV with severe aortic complications.
- Further research into targeted biologic therapies for refractory vasculitis is warranted.
Related Concept Videos
Aneurysm I: Introduction
396
An aortic aneurysm is a localized outpouching or dilation at a weak point in the artery wall. It may involve different parts of the aorta, such as the abdominal aorta, aortic arch, or thoracic aorta.Etiological factorsSeveral disorders are associated with aortic aneurysms.Congenital causes, such as primary connective tissue disorders like Marfan syndrome, impact the integrity and strength of connective tissues, notably affecting the aorta. Marfan syndrome is a genetic disorder that specifically...
396
Aneurysm IV: Nursing Management
409
Vigilant monitoring for aneurysm rupture is essential for patients undergoing aortic surgery.Preoperative Nursing ManagementContinuously monitor the patient for manifestations of aneurysm rupture, such as pallor, weakness, tachycardia, hypotension, abdominal, back, groin, or periumbilical pain, changes in consciousness, and a pulsating abdominal mass. Regularly assess the patient's peripheral pulses.Instruct the patient to consume a clear liquid diet the day before surgery and administer...
409
Aneurysm III: Interprofessional Care
274
Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
274
Aortic Regurgitation I: Introduction
554
IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
554
Aneurysm II: Clinical Manifestations and Diagnostic Studies
328
Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
328
Aortic Regurgitation III: Medical Management
423
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
423

